377 related articles for article (PubMed ID: 30900905)
1. In Vitro Dissolution Model Can Predict the in Vivo Taste Masking Performance of Coated Multiparticulates.
Keeley A; Teo M; Ali Z; Frost J; Ghimire M; Rajabi-Siahboomi A; Orlu M; Tuleu C
Mol Pharm; 2019 May; 16(5):2095-2105. PubMed ID: 30900905
[TBL] [Abstract][Full Text] [Related]
2. Is rat a good model for assessment of particulate-based taste-masked formulations?
Ali J; Chiang M; Lee JB; Voronin GO; Bennett J; Cram A; Kagan L; Garnett MC; Roberts CJ; Gershkovich P
Eur J Pharm Biopharm; 2020 Jan; 146():1-9. PubMed ID: 31726218
[TBL] [Abstract][Full Text] [Related]
3. Taste Masking of Granulated Acetaminophen by Water Insoluble Ethylcellulose Coating.
Bansal A; Krieg B; Sharma N; McGinnis J; Bhatia I; Paz C
Folia Med (Plovdiv); 2021 Feb; 63(1):97-104. PubMed ID: 33650402
[TBL] [Abstract][Full Text] [Related]
4. Formulation and development of oral dry suspension using taste masked Ornidazole particles prepared using Kollicoat(®) Smartseal 30 D.
Chivate A; Sargar V; Nalawade P; Tawde V
Drug Dev Ind Pharm; 2013 Jul; 39(7):1091-7. PubMed ID: 22900982
[TBL] [Abstract][Full Text] [Related]
5. Micropellets coated with Kollicoat
Dashevskiy A; Mohylyuk V; Ahmed AR; Kolter K; Guth F; Bodmeier R
Drug Dev Ind Pharm; 2017 Sep; 43(9):1548-1556. PubMed ID: 28478689
[TBL] [Abstract][Full Text] [Related]
6. Building Process Understanding of Fluid Bed Taste Mask Coating of Microspheres.
Silva BS; Santangelo M; Colbert MJ; Fauteux-Lefebvre C; Bartlett JA; Lapointe-Garant PP; Gosselin R
AAPS PharmSciTech; 2019 Apr; 20(5):173. PubMed ID: 31020426
[TBL] [Abstract][Full Text] [Related]
7. Composition-Property Relationships of pH-Responsive Poly[(2-vinylpyridine)-co-(butyl methacrylate)] Copolymers for Reverse Enteric Coatings.
Brewer K; Blencowe A
Pharmaceutics; 2023 Jan; 15(2):. PubMed ID: 36839776
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo investigation of taste-masking effectiveness of Eudragit E PO as drug particle coating agent in orally disintegrating tablets.
Drašković M; Medarević D; Aleksić I; Parojčić J
Drug Dev Ind Pharm; 2017 May; 43(5):723-731. PubMed ID: 27494420
[TBL] [Abstract][Full Text] [Related]
9. Dissolution methodology for taste masked oral dosage forms.
Gittings S; Turnbull N; Roberts CJ; Gershkovich P
J Control Release; 2014 Jan; 173():32-42. PubMed ID: 24184344
[TBL] [Abstract][Full Text] [Related]
10. Multiparticulate system combining taste masking and immediate release properties for the aversive compound praziquantel.
Münster M; Schoch C; Schmidt C; Breitkreutz J
Eur J Pharm Sci; 2017 Nov; 109():446-454. PubMed ID: 28887230
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Chlorpheniramine Maleate microparticles in orally disintegrating film and orally disintegrating tablet for pediatrics.
Lou H; Liu M; Qu W; Hu Z; Brunson E; Johnson J; Almoazen H
Drug Dev Ind Pharm; 2014 Jul; 40(7):910-8. PubMed ID: 23621768
[TBL] [Abstract][Full Text] [Related]
12. Development and optimisation of simulated salivary fluid for biorelevant oral cavity dissolution.
Ali J; Bong Lee J; Gittings S; Iachelini A; Bennett J; Cram A; Garnett M; Roberts CJ; Gershkovich P
Eur J Pharm Biopharm; 2021 Mar; 160():125-133. PubMed ID: 33524535
[TBL] [Abstract][Full Text] [Related]
13. Solid state characterisation and taste masking efficiency evaluation of polymer based extrudates of isoniazid for paediatric administration.
Keating AV; Soto J; Tuleu C; Forbes C; Zhao M; Craig DQM
Int J Pharm; 2018 Feb; 536(2):536-546. PubMed ID: 28687346
[TBL] [Abstract][Full Text] [Related]
14. Structural and in vitro in vivo evaluation for taste masking.
Al-Kasmi B; Al Rahal O; El-Zein H; Nattouf AH
Expert Opin Drug Deliv; 2018 Nov; 15(11):1105-1116. PubMed ID: 30311503
[TBL] [Abstract][Full Text] [Related]
15. Development and optimization of taste-masked orally disintegrating tablets (ODTs) of clindamycin hydrochloride.
Cantor SL; Khan MA; Gupta A
Drug Dev Ind Pharm; 2015; 41(7):1156-64. PubMed ID: 25000481
[TBL] [Abstract][Full Text] [Related]
16. Taste-masking methods in multiparticulate dosage forms with a focus on poorly soluble drugs.
Simšič T; Planinšek O; Baumgartner A
Acta Pharm; 2024 Jun; 74(2):177-199. PubMed ID: 38815202
[TBL] [Abstract][Full Text] [Related]
17. Development and evaluation of dapsone tablets coated for specific colon release.
Barros PD; Dias IFT; Zanin GD; Bunhak ÉJ
Drug Dev Ind Pharm; 2020 Feb; 46(2):246-252. PubMed ID: 31951762
[No Abstract] [Full Text] [Related]
18. Design of taste-masked swellable drug particles using dry-coating technology with mechanical curing.
Saeki I; Kondo K; Furukoshi Y; Watanabe Y; Niwa T
Eur J Pharm Biopharm; 2021 Mar; 160():9-22. PubMed ID: 33472100
[TBL] [Abstract][Full Text] [Related]
19. In vitro dissolution methodology, mini-Gastrointestinal Simulator (mGIS), predicts better in vivo dissolution of a weak base drug, dasatinib.
Tsume Y; Takeuchi S; Matsui K; Amidon GE; Amidon GL
Eur J Pharm Sci; 2015 Aug; 76():203-12. PubMed ID: 25978875
[TBL] [Abstract][Full Text] [Related]
20. Development and evaluation of orally disintegrating tablets comprising taste-masked mirtazapine granules.
Yıldız S; Aytekin E; Yavuz B; Bozdağ Pehlivan S; Vural İ; Ünlü N
Pharm Dev Technol; 2018 Jun; 23(5):488-495. PubMed ID: 28368673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
